“5am-ventures” Archives

Entry Author Date Location
Chrono Therapeutics Scores $47.6M to Advance Anti-Smoking System 09/09/16 San Francisco
Chrono Therapeutics Secures $47,600,000 Series B Financing Round 09/09/16 San Francisco
Cleave Biosciences Receives $37,000,000 Series B Financing 08/09/16 San Francisco
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Bioz, Using Machine Learning to Optimize Biology, Launches With $3M 07/20/16 San Francisco
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Purigen Biosystems Lands $18,200,000 Series A Funding Round 05/18/16 San Francisco
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
IDEAYA Biosciences Secures $46,000,000 Series A Funding Round 05/05/16 San Francisco
Homology Medicines Obtains $43,500,000 Series A Round 05/03/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
Bird Rock Bio Nears Pivotal Trial of New Biologic Drug for RA 03/16/16 San Diego
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Pear Therapeutics Garners $20,000,000 New Financing 02/03/16 San Francisco
Biodesy Receives $10,000,000 Series B Round 01/25/16 San Francisco
Millendo Therapeutics Receives $62,000,000 Series B Funding 01/04/16 Detroit Ann Arbor
Crinetics Pharmaceuticals Lands $40,000,000 Series A Financing Round 11/03/15 San Diego
Crinetics Pharma Raises $40M in Comeback for Ex-Neurocrine Bio Team 11/02/15 San Diego
Arvinas Obtains $41,600,000 Series B Funding 10/21/15 Boston
Portal Instruments Secures $25,000,000 Series B Financing Round 10/20/15 Boston
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital 03/17/15 National
Any Given Cell: Can Biotech Pioneer Steve Fodor Do it Again? 02/13/15 San Francisco
Cidara’s $42M Series B May Bring Fungal Therapy to Patients 02/11/15 San Diego
MoneyTree Reports $121M in MI Venture Deals Last Quarter 07/22/14 Detroit Ann Arbor
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara 06/30/14 San Diego
San Diego Biotech Raises Over $30M to Fight Deadly Fungal Infections 06/25/14 San Diego
Page 1 of 5 next page »